Ogiya Daisuke

講師
学位：博士（医学）

基本情報

所属

Undergraduate School of Medicine / Faculty of Medicine

詳細情報

論文

Improvement in anemia and symptoms after switching from crovalimab to iptacopan in paroxysmal nocturnal hemoglobinuria.

IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs.

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes.

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.

ALK-negative anaplastic large cell lymphoma with TP53 mutation developing during the administration of baricitinib for atopic dermatitis - A case report.

Bilateral Hilar and Mediastinal Lymphadenopathy as an Initial Manifestation of Amyloidosis.

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report.

[Disseminated toxoplasmosis after cord blood transplantation diagnosed at autopsy].

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax.

Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies.

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies.

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment.

講演・口頭発表等

Evaluation of the clinical use of thehematologic malignancy gene panel test, HemeSight®, in multiple myeloma
Analysis of three patients with multiple myeloma who underwent HemeSight® at our institution
Two cases of chronic myelomonocytic leukemia analyzed by a gene panel test for hematologic malignancies
A case of acute myeloid leukemia in which a hematological gene panel test was useful for diagnosis and prognostic assessment
A case of paroxysmal nocturnal hemoglobinuria showing improvement in symptoms and hemoglobin levels after switching from crovalimab to iptacopan
IL-6-induced B-cell lineage factors drive myeloma-promoting transcriptional and splicing program
Pirtobrutinib vs idelalisib + rituximab or bendamustine + rituximab in CLL/SLL: East Asia subgroup
A case of multiple myeloma on hemodialysis successfully treated with elranatamab
The clinical analysis of atypical CD38 and CD138 expression patterns in multiple myeloma cases
IL-6-induced B-cell lineage factors contribute to lineage dependency in multiple myeloma
Analysis of genetic alterations in a case of BCR-ABL1-positive myelodysplastic syndrome
A case of disseminated toxoplasmosis after cord blood transplantation for acute myeloid leukemia